FDA Drug Recalls

Recalls / Class II

Class IID-1107-2018

Product

Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9

Affected lot / code info
Lot # G2017F NDC 68788-6882-9

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Recalling firm

Firm
Preferred Pharmaceuticals, Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1250 N Lakeview Ave Ste O, Anaheim, California 92807-1801

Distribution

Quantity
9 bottles consisting of 90 tables each bottle
Distribution pattern
Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.

Timeline

Recall initiated
2018-08-15
FDA classified
2018-08-17
Posted by FDA
2018-08-29
Terminated
2019-01-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1107-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.